Detalles de la búsqueda
1.
Implementing Programs to Initiate Buprenorphine for Opioid Use Disorder Treatment in High-Need, Low-Resource Emergency Departments: A Nonrandomized Controlled Trial.
Ann Emerg Med
; 82(3): 272-287, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37140493
2.
Patient Characteristics Associated with Opioid Abstinence after Participation in a Trial of Buprenorphine versus Injectable Naltrexone.
Subst Use Misuse
; 57(11): 1732-1742, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35975917
3.
Substance Use and Mental Health in Emerging Adult Vs Older Adult Men and Women With Opioid Use Disorder.
Am J Addict
; 29(6): 536-542, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32438502
4.
Cost-Effectiveness of Buprenorphine-Naloxone Versus Extended-Release Naltrexone to Prevent Opioid Relapse.
Ann Intern Med
; 170(2): 90-98, 2019 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30557443
5.
Variants of opioid genes and response to treatment of opioid use disorder with buprenorphine-naloxone versus extended-release naltrexone in Caucasians.
Am J Drug Alcohol Abuse
; 46(6): 761-768, 2020 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32851876
6.
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.
Lancet
; 391(10118): 309-318, 2018 01 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-29150198
7.
Gender differences in demographic and clinical characteristics of patients with opioid use disorder entering a comparative effectiveness medication trial.
Am J Addict
; 27(6): 465-470, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30106494
8.
Endometrial polyps in obese asymptomatic pre and postmenopausal patients with breast cancer: is screening necessary?
Gynecol Oncol
; 133(1): 56-62, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24680592
9.
Target trial emulation for comparative effectiveness research with observational data: Promise and challenges for studying medications for opioid use disorder.
Addiction
; 119(7): 1313-1321, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38519819
10.
Discontinuation of medication treatment for opioid use disorder after a successful course: The discontinuation phase of the CTN-0100 (RDD) trial.
Contemp Clin Trials
; 142: 107543, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38657730
11.
EMDR therapy modulates the default mode network in a subsyndromal, traumatized bipolar patient.
Neuropsychobiology
; 67(3): 181-4, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23548794
12.
Secondary Analysis of Agreement Between Negative Timeline Follow Back Report and Negative Urine Toxicology in a Large Trial of Individuals with Opioid Use Disorder.
J Addict Med
; 17(5): 618-620, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37788622
13.
EMDR therapy vs. supportive therapy as adjunctive treatment in trauma-exposed bipolar patients: A randomised controlled trial.
Span J Psychiatry Ment Health
; 2023 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38061553
14.
Time-lagged association between counseling and/or 12-Step attendance with subsequent opioid use in a secondary analysis from a randomized, clinical trial of medications for opioid use disorder.
Drug Alcohol Depend Rep
; 52022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36644220
15.
High incidence of PTSD diagnosis and trauma-related symptoms in a trauma exposed bipolar I and II sample.
Front Psychiatry
; 13: 931374, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36339849
16.
Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 "optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)".
Addict Sci Clin Pract
; 16(1): 15, 2021 03 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33676577
17.
Sublingual Buprenorphine-Naloxone Compared With Injection Naltrexone for Opioid Use Disorder: Potential Utility of Patient Characteristics in Guiding Choice of Treatment.
Am J Psychiatry
; 178(7): 660-671, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34170188
18.
Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse.
J Subst Abuse Treat
; 131: 108447, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34098301
19.
Cost-effectiveness implications of increasing the efficiency of the extended-release naltrexone induction process for the treatment of opioid use disorder: a secondary analysis.
Addiction
; 116(12): 3444-3453, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33950535
20.
Implementation facilitation to introduce and support emergency department-initiated buprenorphine for opioid use disorder in high need, low resource settings: protocol for multi-site implementation-feasibility study.
Addict Sci Clin Pract
; 16(1): 16, 2021 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33750454